Fig. 6
From: Tumor microenvironment-responsive BSA nanocarriers for combined chemo/chemodynamic cancer therapy
Combined chemo/chemodynamic therapy in vivo. a Tumor growth curves monitored for 14 days after various treatments. b Tumor weight in each group 14 days after each treatment. c Hematoxylin and eosin (H&E) and TUNEL stained tumor slice post specific treatment. The error bars were based on the standard deviation of 6 mice in each group. P values in (a) were calculated by multiple t tests (****P < 0.0001, ***P < 0.001, ***P < 0.001, **P < 0.01, *P < 0.05)